MARKET

CTSO

CTSO

Cytosorbents Corp
NASDAQ
5.81
+0.01
+0.09%
Opening 14:01 11/11 EST
OPEN
5.95
PREV CLOSE
5.80
HIGH
5.95
LOW
5.50
VOLUME
20.11K
TURNOVER
--
52 WEEK HIGH
17.00
52 WEEK LOW
2.840
MARKET CAP
18.29M
P/E (TTM)
-1.0005
1D
5D
1M
3M
1Y
5Y
1D
CytoSorbents to Participate at the 2026 Jefferies Global Healthcare Conference in London
PR Newswire · 2d ago
Weekly Report: what happened at CTSO last week (1102-1106)?
Weekly Report · 2d ago
Weekly Report: what happened at CTSO last week (1026-1030)?
Weekly Report · 11/02 10:08
CytoSorbents to Report Third Quarter 2026 Financial Results and Recent Business Highlights
PR Newswire · 10/29 11:00
Weekly Report: what happened at CTSO last week (1019-1023)?
Weekly Report · 10/26 10:07
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 10/23 21:05
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 10/22 05:30
Cytosorbents Initiated at Speculative Buy by WBB Securities
Dow Jones · 10/21 16:25
More
About CTSO
CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery through blood purification. The Company’s blood purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its lead product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses that can lead to massive inflammation, organ failure and patient death. Its products also include ECOS-300CY, VetResQ, DrugSorb-ATR, and PuriFi. DrugSorb-ATR is an investigational device that uses equivalent polymer technology to CytoSorb to address a large unmet need for blood thinner reversal in cardiothoracic surgery. ECOS-300CY is used to reduce cytokines and other inflammatory mediators when used in an ex vivo organ perfusion system.

Webull offers Cytosorbents Corp stock information, including NASDAQ: CTSO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTSO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CTSO stock methods without spending real money on the virtual paper trading platform.